Skip to main content

What the FDA labels say about taking them together

Colestipol and mycophenolic acid

Colestipol's FDA label of February 19, 2024 names mycophenolic acid in its drug interactions section; the mycophenolic acid label PlainMeds reads does not name colestipol. The colestipol label: “A study has shown that cholestyramine binds bile acids and reduces mycophenolic acid exposure.”

Check it at the source: the colestipol FDA label on DailyMed (effective February 19, 2024, Zydus Pharmaceuticals USA Inc.); the mycophenolic acid FDA label on DailyMed (effective July 29, 2026, Novartis Pharmaceuticals Corporation).

What does the colestipol label say about mycophenolic acid?

Colestipol label, drug interactions

A study has shown that cholestyramine binds bile acids and reduces mycophenolic acid exposure.

Source: FDA drug label (Colestipol hydrochloride), Zydus Pharmaceuticals USA Inc., effective February 19, 2024 (SPL set 71f12e0d-373a-4867-b37c-f24d99c5ce95), via openFDA; the full label on DailyMed

What does the mycophenolic acid label say about colestipol?

Mycophenolic acid's label (effective July 29, 2026) does not name colestipol in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (Myfortic), Novartis Pharmaceuticals Corporation, effective July 29, 2026 (SPL set eed26501-890d-4ff6-88e7-6dbea4726e53), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

8Colestipol generic labelers
16Mycophenolic acid generic labelers
ColestipolMycophenolic acid
Labeled forHigh cholesterolOrgan transplant rejection
Boxed warningNoYes
Pharmacy cost (NADAC)$0.658 per tablet 1 g tablet$0.0996 per tablet 180 mg tablet
Shortage nowNo current entryNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?